During the past decade, TriCities Skin and Cancer conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "TriCities Skin and Cancer" are "Papulopustular Rosacea" (1 trials) and "Papulopustular Rosacea (PPR)" (1 trials). Many other conditions were trialed in "TriCities Skin and Cancer" in a lesser frequency.

Most popular intervention types in "TriCities Skin and Cancer" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Azelaic acid 15% Gel" (1 trials), "CD5024" (1 trials), "omiganan" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "TriCities Skin and Cancer" are 2 trials for "All" genders.

Currently, there are NaN active trials in "TriCities Skin and Cancer". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in TriCities Skin and Cancer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TriCities Skin and Cancer, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".